☆ 4.7 Article

Long-Term Outcomes of the PRESERFLO MicroShunt Implant in a Heterogeneous Glaucoma Cohort

JOURNAL OF CLINICAL MEDICINE (2023)

Related references

Note: Only part of the references are listed.

Article Ophthalmology

One-year outcomes of stand-alone ab externo SIBS microshunt implantation in refractory glaucoma

Georges M. Durr et al.

Summary: This study evaluated the efficacy and complications of the SIBS microshunt in glaucomatous eyes refractory to previous subconjunctival filtering surgery over the past year. The results showed that the SIBS microshunt had reasonable surgical success and few complications in patients who had previously undergone unsuccessful filtering surgery.

BRITISH JOURNAL OF OPHTHALMOLOGY (2022)

Add to Collection

Article Ophthalmology

PRESERFLO (TM) MicroShunt versus trabeculectomy: first results on efficacy and safety

Karin R. Pillunat et al.

Summary: The PRESERFLO (TM) MicroShunt and trabeculectomy showed similar efficacy and safety outcomes in patients with primary open-angle glaucoma. However, the MicroShunt procedure may be preferred earlier in the treatment of glaucoma due to its less invasiveness and lower need for postoperative interventions.

ACTA OPHTHALMOLOGICA (2022)

Add to Collection

Review Clinical Neurology

Acetazolamide: Old drug, new evidence?

Arif Ali Shukralla et al.

Summary: Acetazolamide, an old antiepileptic drug, acts as a noncompetitive inhibitor of carbonic anhydrase. It may reduce seizure frequency by activating acid-sensing ion channels and modulating neuroinflammation. The clinical efficacy of acetazolamide is supported by observational studies, but further randomized placebo-controlled trials are needed to assess its effectiveness and safety.

EPILEPSIA OPEN (2022)

Add to Collection

Letter Ophthalmology

Re: Beckers et al.: Safety and effectiveness of the PRESERFLO® MicroShunt in primary open-angle glaucoma: results from a 2-year multicenter study. Ophthalmol Glaucoma (2021;doi 10.1016/j.ogla.2021.07.008: Jul 28 [Epub ahead of print].)

T. H. O. M. A. S. E. D. W. A. R. D. J. A. M. E. S. SHERMAN et al.

OPHTHALMOLOGY GLAUCOMA (2022)

Add to Collection

Article Ophthalmology

XEN(R)Gel Stent compared to PRESERFLO™ MicroShunt implantation for primary open-angle glaucoma: two-year results

Lotte M. J. Scheres et al.

Summary: Xen Gel Stent and PreserFlo MicroShunt implantations achieved comparable results in terms of IOP-lowering and surgical success in POAG eyes, with a similar high safety profile.

ACTA OPHTHALMOLOGICA (2021)

Add to Collection

Article Ophthalmology

Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma One-Year Results from a 2-Year Randomized, Multicenter Study

N. Douglas Baker et al.

Summary: The study compared the effectiveness and safety of the MicroShunt versus trabeculectomy in treating POAG, finding that trabeculectomy had higher success rates and greater reduction in intraocular pressure.

OPHTHALMOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

One-year outcomes of microshunt implantation in pseudoexfoliation glaucoma

Matthias Nobl et al.

Summary: This study compared the safety and efficacy of microshunt implantation augmented with Mitomycin C in patients with PEXG and POAG, showing similar efficacy results in both groups at a 12-month follow-up, but higher rates of transient hypotony and choroidal detachment were observed in PEXG eyes.

PLOS ONE (2021)

Add to Collection

Article Multidisciplinary Sciences

Clinical outcomes of combined Preserflo Microshunt implantation and cataract surgery in open-angle glaucoma patients

Jose M. Martinez-de-la-Casa et al.

Summary: The study evaluated the effectiveness and safety of Preserflo Microshunt (PMS) implantation combined with cataract surgery in patients with open-angle glaucoma. Results showed a significant reduction in intraocular pressure, decreased use of ocular hypotensive medication, and a good success rate for this treatment option.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Ophthalmology

Long-term Results of the PRESERFLO MicroShunt in Patients With Primary Open-angle Glaucoma From a Single-center Nonrandomized Study

Juan F. Batlle et al.

Summary: The MicroShunt was successfully implanted in 23 patients with primary open-angle glaucoma (POAG) in a feasibility study, resulting in sustained reductions in intraocular pressure (IOP) and medication use for up to 5 years without any long-term sight-threatening adverse events. This demonstrates the long-term effectiveness and safety of the MicroShunt in managing POAG patients inadequately controlled on other therapies.

JOURNAL OF GLAUCOMA (2021)

Add to Collection

Review Ophthalmology

Surgical Management of Pseudoexfoliative Glaucoma: A Review of Current Clinical Considerations and Surgical Outcomes

Kevin Gillmann et al.

Summary: Pseudoexfoliative glaucoma (PEXG) is the most common cause of secondary open-angle glaucoma worldwide and is more resistant to conventional treatments. Accurate and timely diagnosis, frequent glaucoma assessments, and patient education are crucial. Surgical interventions such as cataract extraction, XEN 45 gel stents, and glaucoma drainage devices may offer better outcomes in PEXG compared to primary open-angle glaucoma, but further studies are needed to define optimal management practices.

JOURNAL OF GLAUCOMA (2021)

Add to Collection

Article Ophthalmology

The Effects of Trabeculectomy on Pseudoexfoliation Glaucoma and Primary Open-Angle Glaucoma

Fan Li et al.

JOURNAL OF OPHTHALMOLOGY (2020)

Add to Collection

Article Ophthalmology

Intermediate Outcomes of a Novel Standalone Ab Externo SIBS Microshunt With Mitomycin C

Matthew B. Schlenker et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2020)

Add to Collection

Review Medicine, General & Internal

Current management of glaucoma

Jed Lusthaus et al.

MEDICAL JOURNAL OF AUSTRALIA (2019)

Add to Collection

Review Ophthalmology

Review of the Xen Gel Stent and InnFocus MicroShunt

Wesley Green et al.

CURRENT OPINION IN OPHTHALMOLOGY (2018)

Add to Collection

Article Ophthalmology

Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up

Steven J. Gedde et al.

OPHTHALMOLOGY (2018)

Add to Collection

Article Ophthalmology

Three-Year Follow-up of a Novel Aqueous Humor MicroShunt

Juan F. Batlle et al.

JOURNAL OF GLAUCOMA (2016)

Add to Collection

Review Medicine, General & Internal

The Pathophysiology and Treatment of Glaucoma A Review

Robert N. Weinreb et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)

Add to Collection

© Peeref 2019-2024. All rights reserved.